Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institut Pasteur Production (IPP) was the industrial and commercial subsidiary of the Institut Pasteur, established in 1972 to manage the large-scale manufacturing and distribution of vaccines and diagnostic reagents. Founded under the leadership of Jacques Monod, the company was created to bridge the gap between the institute's research and public health needs, notably producing the first vaccines for hepatitis B and maintaining a global supply of rabies vaccines. In 1985, IPP was acquired by the Institut Mérieux, a move that consolidated French vaccine production and eventually led to the formation of Sanofi Pasteur. Today, its legacy and facilities, such as the Val de Reuil site, remain integral to Sanofi's global vaccine operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pasteur Production.